Search Results 571-580 of 16699 for CLL

  1. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

  2. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

  3. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

  4. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

  5. Chemotherapy Clinical Trials - Mayo Clinic Research

    This study evaluates CLR 131 in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/small ...

  6. Skin Cancer Clinical Trials - Mayo Clinic Research

    ... Chronic Lymphocytic Leukemia Rochester, MN. The purpose of this study is ... CLL as well as non-CLL patients. Study of IDO Inhibitor in Combination With ...

  7. Robotic surgery - Doctors & Departments - Mayo Clinic

    Robotic systems can help surgeons increase precision, flexibility and control for many procedures. Learn about the advantages and availability of ...

  8. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    INCLUDING: any non-Hodgkin's B-cell malignancy such as CLL and rare non-Hodgkin's B-cell subtypes such as Hairy Cell Leukemia, Waldenstrom macroglobulinemia, ...

  9. Popliteal artery aneurysm - Doctors and departments - Mayo Clinic

    Learn more about this lower extremity aneurysm that occurs in the wall of an artery located behind the knee.

  10. A Study of Leukemia Inhibitory Factor Biomarker Monitoring Progression and Treatment Response of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies - Mayo Clinic

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...